Effects of cigarette smoke condensate on pneumococcal biofilm formation and pneumolysin

Although the well-recognised predisposition of cigarette smokers to the development of severe pneumococcal disease may be attributable to impairment of local host defences, less is known about the direct effects of smoke exposure on airway pathogens, or their virulence factors. In the current study, we have investigated the effects of cigarette smoke condensate (CSC) on biofilm formation by Streptococcus pneumoniae, and on the pore-forming activity of its major toxin, pneumolysin. Biofilm formation following exposure of the pneumococcus to CSC (20-160 μg·mL(-1)) was measured using a crystal violet-based spectrophotometric procedure, while the pore-forming activity of recombinant pneumolysin was determined by a fura-2/acetoxymethyl ester-based spectrofluorimetric procedure to monitor the uptake of extracellular Ca(2+) by isolated human neutrophils. Exposure of the pneumococcus or pneumolysin to CSC resulted in significant dose-related augmentation of biofilm formation (p≤0.05 at 80 and 160 μg·mL(-1)) and substantial attenuation of the pore-forming interactions of pneumolysin, respectively. Augmentation of biofilm formation and inactivation of pneumolysin as a consequence of smoking are likely to favour microbial colonisation and persistence, both being essential precursors of pneumococcal disease.

Medienart:

E-Artikel

Erscheinungsjahr:

2013

Erschienen:

2013

Enthalten in:

Zur Gesamtaufnahme - volume:41

Enthalten in:

The European respiratory journal - 41(2013), 2 vom: 27. Feb., Seite 392-5

Sprache:

Englisch

Beteiligte Personen:

Mutepe, N Daphney [VerfasserIn]
Cockeran, Riana [VerfasserIn]
Steel, Helen C [VerfasserIn]
Theron, Annette J [VerfasserIn]
Mitchell, Tim J [VerfasserIn]
Feldman, Charles [VerfasserIn]
Anderson, Ronald [VerfasserIn]

Links:

Volltext

Themen:

Bacterial Proteins
Calcium
Fluorescent Dyes
Fura-2
Journal Article
PlY protein, Streptococcus pneumoniae
Research Support, Non-U.S. Gov't
SY7Q814VUP
Streptolysins
TSN3DL106G

Anmerkungen:

Date Completed 30.07.2013

Date Revised 10.04.2022

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1183/09031936.00213211

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM219021570